Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, .001 par value per share
-
Shares outstanding
-
30.3M
-
Number of holders
-
23
-
Total shares
-
17.7M
-
Shares change
-
+313K
-
Total reported value, excl. options
-
$82M
-
Value change
-
+$1.75M
-
Number of buys
-
12
-
Number of sells
-
-5
-
Price
-
$4.64
Significant Holders of NeuroPace Inc - Common Stock, .001 par value per share (NPCE) as of Q1 2023
23 filings reported holding NPCE - NeuroPace Inc - Common Stock, .001 par value per share as of Q1 2023.
NeuroPace Inc - Common Stock, .001 par value per share (NPCE) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
of 30.3M outstanding shares and own 58.4% of the company stock.
Largest 10 shareholders include KCK LTD. (5.62M shares), ORBIMED ADVISORS LLC (4.01M shares), Soleus Capital Management, L.P. (2.43M shares), MORGAN STANLEY (2.26M shares), FMR LLC (1.49M shares), MILLENNIUM MANAGEMENT LLC (732K shares), Nantahala Capital Management, LLC (426K shares), VANGUARD GROUP INC (297K shares), Kent Lake Capital LLC (128K shares), and GEODE CAPITAL MANAGEMENT, LLC (71.5K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.